Can-Fite BioPharma
CANF | AMEX
$1.56
+$0.14 (+9.86%)
At close: Nov 16, 2026, 4:00 PM ET
$1.56
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:00 PM ET
+9.86%
(1D)No price chart data available for 1D timeframe.
Rating
37
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #611/1021 (Top 60%)
Key Statistics
Market Data
Market Cap $5.79M
1D Range
1.46 1.56
52W Range
1.42 7.80
Valuation (TTM)
PE -1.24
PB 1.19
EV/EBITDA 0.12
Valuation (NTM)
Forward PE 2.75
Forward PEG -0.00
Price Target $8.00
Cash Flow
FCF Yield -164.3%
SBC Adj. FCF Yield -167.4%
SBC Impact -1.9%
Margins
Gross Margin 100.0%
Operating Margin -2403.0%
FCF Margin -2348.9%
Growth (CAGR)
Revenue 3Y | 5Y -20.1% |
-11.8%
Dil EPS 3Y | 5Y -147.1% |
-90.2%
FCF 3Y | 5Y -36.7% |
-64.4%
Returns
ROA -118.6%
ROE -182.9%
ROIC -165.6%
Financial Health
Net Cash
$7.04M
Current Ratio 3.60
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Can-Fite BioPharma Ltd., an Israeli clinical-stage biopharmaceutical company, specializes in the creation of small molecule therapeutic products. These treatments target a range of conditions includin...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Nov 6, 2012
Website www.canfite.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$8.00
Upside
+412.82%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CANF